Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Business Officer Cambridge, UK, and Boston, MA, USA — Nuclera, the biotechnology company enabling access to innovative protein technologies, today announced […]
MARLBOROUGH, Mass. — Scitara, the Lab Connectivity and AI platform company serving the life sciences and biopharma industries, today announced a new strategic direction for the company alongside the appointment of Mike Tarselli, Ph.D., MBA, as Chief Strategy Officer. The moves mark Scitara’s evolution from a lab connectivity provider into a multi-vendor lab intelligence company. […]
REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the Company’s President, Chief Financial Officer and Treasurer, will depart Seer effective October 1, 2026, to pursue a new opportunity at a private company. Charles Endweiss, who has […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner will oversee the company’s global finance organization, including financial planning and analysis, accounting, treasury, […]
Lightcast Appoints Sarah Taylor as Vice President of Science Former 10x Genomics leader will help accelerate application development and commercial growth for Envisia™ single-cell analysis platform Cambridge, England – Lightcast,a pioneering life science tools company focused on functional single-cell analysis, today announced the appointment of Sarah Taylor, PhD, as Vice President of Science, effective immediately. She […]
BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix, partnering closely with the company’s Diagnostics, Scientific, R&D, Regulatory, and […]
VIENNA — Cell-free DNA assembly pioneer, Ribbon Bio, has today announced the appointment of Jay Therrien as Chief Business Officer. Therrien joins Ribbon’s executive leadership team where he will lead the company’s commercial strategy and growth initiatives. Therrien brings over two decades of experience building and leading commercial organizations across the life sciences and genomics […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company’s board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of service as a director. Koh joined Agilent’s board in 2003 and served as independent chair from 2017 until […]
Current Director Dr. Martin Madaus Appointed Interim CEO Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”) today announced that current member of the Board of Directors (the “Board”) Dr. Martin Madaus has been appointed interim President and CEO, and that John […]
Jon Pratt brings more than 25 years of leadership experience, most recently as CEO of Filtration Group and previously at Waters, Beckman Coulter Life Sciences and Pall To assume CEO role on September 1, 2026, succeeding Thierry Bernard QIAGEN reaffirms outlook for the third quarter and full-year 2026; strategic review continues VENLO, Netherlands — QIAGEN […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
